Search Result "Flushing syndrome"
Diet and Metabolic Syndrome
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 124-137
Author(s): L. Djousse, H. Padilla, T.L. Nelson, J.M. Gaziano, K.J. Mukamal
Medicinal Agents and Metabolic Syndrome
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 2 Year: 2013 Page: 2626-2640
Author(s): M.E. Rubio-Ruiz, M. El Hafidi, I. Perez-Torres, G. Banos, V. Guarner
Pharmacologic Treatment of Restless Legs Syndrome
Journal: Current Neuropharmacology
Volume: 19 Issue: 3 Year: 2021 Page: 372-382
Author(s): Qing Lv,Xinlin Wang,Tetsuya Asakawa,Xiao Ping Wang
Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3446-3462
Author(s): M. Florentin, M. S. Elisaf, D. P. Mikhailidis, E. N. Liberopoulos
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
Pharmacotherapy of Mixed Dyslipidemia in the Metabolic Syndrome
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 133-139
Author(s): Kei Nakajima
Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 1 Year: 2016 Page: 37-47
Author(s): Alejandro Avila-Alvarez,Maria Jesus del Cerro Marin,Victor Bautista-Hernandez
What Restricts the Clinical Use of Nicotinic Acid?
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 4 Year: 2011 Page: 521-530
Author(s): Anastazia Kei, Evangelos N. Liberopoulos, Moses S. Elisaf
Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 450-463
Author(s): Kosmas I. Paraskevas, Gabriel Karatzas, Alkisti Pantopoulou, Dimitrios G. Iliopoulos, Despina Perrea
Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5025-5038
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold